Literature DB >> 16563482

Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test.

Joseph E Gaugler1, Edward Pavlik, John M Salsman, Michael A Andrykowski.   

Abstract

OBJECTIVE: While cancer screening can reduce morbidity and mortality, screening can also be associated with adverse physical, psychological, and behavioral outcomes, even when no malignancy is detected. Few studies, however, have comprehensively examined the potential positive impact of a normal cancer screening test result. This study examined the effects of receipt of a normal ovarian cancer screening test result on a range of psychosocial outcomes, including screening-related beliefs and intentions, risk knowledge, distress, and positive affect.
METHOD: The present study utilized baseline, 2-week, and 4-month data from a sample of 560 asymptomatic women who underwent a routine screening for ovarian cancer and received a normal result as well as 296 controls (Lexington, Kentucky, USA, 2000-2002).
RESULTS: Growth curve modeling revealed that receipt of a "normal" test result following ovarian cancer screening was associated with increased beliefs in the efficacy of ovarian cancer screening, decreased ovarian cancer-related distress, increased knowledge of ovarian cancer risk factors, and increased positive affect over the 4-month study period.
CONCLUSION: Receipt of a normal ovarian cancer screening test result influences a range of affective and cognitive endpoints. For the most part, these endpoints are either empirically or theoretically linked to likelihood of participation in future cancer screening. Thus, participation in routine ovarian cancer screening with receipt of a normal screening test result may create a set of affective and cognitive conditions that facilitate repeat screening and contribute to the maintenance of appropriate ovarian cancer screening behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563482     DOI: 10.1016/j.ypmed.2006.02.004

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  4 in total

1.  Receipt of a false positive test result during routine screening for ovarian cancer: a teachable moment?

Authors:  Andrea Floyd; Rachel F Steffens; Edward Pavlik; Michael A Andrykowski
Journal:  J Clin Psychol Med Settings       Date:  2011-03

2.  Effects of Demographics and OTC Analgesics on Ovarian Cancer Symptoms.

Authors:  Kimberly A Lowe; M Robyn Andersen; Jeannette C Kane; Marissa D Robertson; Barbara A Goff
Journal:  J Nurse Pract       Date:  2013-01       Impact factor: 0.767

Review 3.  Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.

Authors:  Eleanor L Ormsby; Edward J Pavlik; John P McGahan
Journal:  Diagnostics (Basel)       Date:  2017-04-28

Review 4.  Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening.

Authors:  Michael A Andrykowski
Journal:  Diagnostics (Basel)       Date:  2017-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.